Segment and Other Information (Details) $ in Millions	3 Months Ended		6 Months Ended
	Feb. 29, 2024 USD ($)	Mar. 02, 2023 USD ($)	Feb. 29, 2024 USD ($) segment	Mar. 02, 2023 USD ($)
Reportable Segments
Number of reportable segments | segment			4
Net sales
Revenue	$ 5,824	$ 3,693	$ 10,550	$ 7,778
Operating income (loss)
Operating income (loss)	191	(2,303)	(937)	(2,512)
Unallocated
Patent cross-license agreement gain	200	0	200	0
Stock-based compensation	(209)	(133)	(391)	(259)
Restructure and asset impairments	0	(86)	0	(99)
Provision to write-down inventories to net realizable value			0	(1,430)
Operating Segments
Operating income (loss)
Operating income (loss)	(178)	(647)	(1,738)	(712)
Unallocated
Operating income (loss)
Operating income (loss)	369	(1,656)	801	(1,800)
Unallocated
Lower costs from sale of inventory written down in prior periods	382	0	987	0
Patent cross-license agreement gain	200	0	200	0
Stock-based compensation	(209)	(136)	(391)	(262)
Restructure and asset impairments	0	(86)	0	(99)
Provision to write-down inventories to net realizable value	0	(1,430)	0	(1,430)
Other	(4)	(4)	5	(9)
CNBU
Net sales
Revenue	2,185	1,375	3,922	3,121
CNBU | Operating Segments
Operating income (loss)
Operating income (loss)	28	(35)	(369)	155
MBU
Net sales
Revenue	1,598	945	2,891	1,600
MBU | Operating Segments
Operating income (loss)
Operating income (loss)	(9)	(344)	(696)	(539)
EBU
Net sales
Revenue	1,111	865	2,148	1,865
EBU | Operating Segments
Operating income (loss)
Operating income (loss)	(1)	88	9	282
SBU
Net sales
Revenue	905	507	1,558	1,187
SBU | Operating Segments
Operating income (loss)
Operating income (loss)	(217)	(357)	(707)	(614)
All Other
Net sales
Revenue	25	1	31	5
All Other | Operating Segments
Operating income (loss)
Operating income (loss)	$ 21	$ 1	$ 25	$ 4